These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


281 related items for PubMed ID: 25269440

  • 21. Oxalobacter formigenes Colonization and Oxalate Dynamics in a Mouse Model.
    Li X, Ellis ML, Knight J.
    Appl Environ Microbiol; 2015 Aug; 81(15):5048-54. PubMed ID: 25979889
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Characterization of a Bifidobacterium animalis subsp. lactis reference strain based on ecology and transcriptomics.
    Lugli GA, Argentini C, Tarracchini C, Mancabelli L, Viappiani A, Anzalone R, Angelini L, Alessandri G, Longhi G, Bianchi MG, Taurino G, Bussolati O, Milani C, Turroni F, Ventura M.
    Appl Environ Microbiol; 2024 Oct 23; 90(10):e0108024. PubMed ID: 39235395
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Intestinal colonization with Oxalobacter formigenes and its relation to urinary oxalate excretion in pediatric patients with idiopathic calcium urolithiasis.
    Sikora P, Niedźwiadek J, Mazur E, Paluch-Oleś J, Zajaczkowska M, Kozioł-Montewka M.
    Arch Med Res; 2009 Jul 23; 40(5):369-73. PubMed ID: 19766900
    [Abstract] [Full Text] [Related]

  • 32. Oxalobacter formigenes and its potential role in human health.
    Duncan SH, Richardson AJ, Kaul P, Holmes RP, Allison MJ, Stewart CS.
    Appl Environ Microbiol; 2002 Aug 23; 68(8):3841-7. PubMed ID: 12147479
    [Abstract] [Full Text] [Related]

  • 33. Reduction of plasma oxalate levels by oral application of Oxalobacter formigenes in 2 patients with infantile oxalosis.
    Hoppe B, Dittlich K, Fehrenbach H, Plum G, Beck BB.
    Am J Kidney Dis; 2011 Sep 23; 58(3):453-5. PubMed ID: 21705122
    [Abstract] [Full Text] [Related]

  • 34. A randomised Phase II/III study to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria.
    Milliner D, Hoppe B, Groothoff J.
    Urolithiasis; 2018 Aug 23; 46(4):313-323. PubMed ID: 28718073
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis.
    Hoppe B, von Unruh GE, Blank G, Rietschel E, Sidhu H, Laube N, Hesse A.
    Am J Kidney Dis; 2005 Sep 23; 46(3):440-5. PubMed ID: 16129205
    [Abstract] [Full Text] [Related]

  • 37. Association of absence of intestinal oxalate degrading bacteria with urinary calcium oxalate stone formation.
    Mikami K, Akakura K, Takei K, Ueda T, Mizoguchi K, Noda M, Miyake M, Ito H.
    Int J Urol; 2003 Jun 23; 10(6):293-6. PubMed ID: 12757596
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The Effect of Calcium and Vitamin B6 Supplementation on Oxalate Excretion in a Rodent Gastric Bypass Model of Enteric Hyperoxaluria.
    Espino-Grosso P, Monsour C, Canales BK.
    Urology; 2019 Feb 23; 124():310.e9-310.e14. PubMed ID: 30412704
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.